Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Healthequity (HQY) Operating Expenses (2016 - 2026)

Healthequity has reported Operating Expenses over the past 14 years, most recently at $157.1 million for Q1 2026.

  • For Q1 2026, Operating Expenses rose 6.93% year-over-year to $157.1 million; the TTM value through Jan 2026 reached $590.7 million, down 3.95%, while the annual FY2026 figure was $590.7 million, 3.95% down from the prior year.
  • Operating Expenses for Q1 2026 was $157.1 million at Healthequity, up from $149.4 million in the prior quarter.
  • Over five years, Operating Expenses peaked at $177.4 million in Q4 2024 and troughed at $118.9 million in Q2 2022.
  • A 5-year average of $136.8 million and a median of $132.9 million in 2022 define the central range for Operating Expenses.
  • Biggest five-year swings in Operating Expenses: soared 38.28% in 2024 and later decreased 15.8% in 2025.
  • Year by year, Operating Expenses stood at $121.8 million in 2022, then grew by 5.35% to $128.3 million in 2023, then surged by 38.28% to $177.4 million in 2024, then decreased by 15.8% to $149.4 million in 2025, then increased by 5.16% to $157.1 million in 2026.
  • Business Quant data shows Operating Expenses for HQY at $157.1 million in Q1 2026, $149.4 million in Q4 2025, and $143.0 million in Q3 2025.